Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AMGN | GILD | BMY | VRTX |
| Company | Intra-Cellular Ther | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 84.16 | 262.18 | 92.62 | 56.93 | 403.14 |
| High | 84.99 | 263.58 | 92.83 | 57.38 | 409.60 |
| Low | 83.75 | 261.25 | 92.03 | 56.73 | 402.72 |
| Last | 84.52 | 261.40 | 92.02 | 57.27 | 406.41 |
| Change | +1.00 | +0.76 | -0.35 | +0.71 | +3.71 |
| % Change | +1.20% | +0.29% | -0.38% | +1.26% | +0.92% |
| Volume | 89,751 | 362,197 | 409,002 | 1,235,601 | 173,884 |
| 20-Day Average Volume | 454,284 | 3,654,953 | 6,639,459 | 10,856,855 | 1,829,922 |
| Previous Close | 83.52 | 260.64 | 92.37 | 56.56 | 402.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 84.55 | 267.44 | 92.41 | 57.34 | 437.35 |
| 20-Day Raw Stochastic | 40.58% | 33.11% | 54.73% | 40.68% | 30.65% |
| 20-Day Relative Strength | 51.26% | 34.03% | 52.21% | 50.74% | 36.46% |
| Weighted Alpha | +25.90 | -18.31 | +20.09 | +16.55 | -9.21 |
| Today's Opinion | 40% Buy | 88% Sell | 88% Buy | 72% Buy | 72% Sell |
| Previous Opinion | 56% Buy | 88% Sell | 88% Buy | 56% Buy | 72% Sell |
| Last Month's Opinion | 88% Buy | 72% Sell | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.85% since 12/24/24 | -0.89% since 12/24/24 | -1.91% since 12/24/24 | -1.39% since 12/24/24 | -0.03% since 12/24/24 |
| Low | 82.32 on 12/30/24 | 258.50 on 12/30/24 | 91.72 on 12/30/24 | 55.93 on 12/31/24 | 399.06 on 12/30/24 |
| High | 86.36 on 12/26/24 | 264.73 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | -1.76% since 12/02/24 | -5.74% since 12/02/24 | -1.98% since 12/02/24 | -4.97% since 12/02/24 | -12.38% since 12/02/24 |
| Low | 81.37 on 12/11/24 | 253.30 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 |
| High | 89.12 on 12/18/24 | 281.38 on 12/03/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +16.38% since 10/02/24 | -18.01% since 10/02/24 | +8.76% since 10/02/24 | +5.95% since 10/02/24 | -11.70% since 10/02/24 |
| Low | 70.90 on 10/07/24 | 253.30 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 | 377.85 on 12/19/24 |
| High | 93.45 on 11/11/24 | 329.17 on 10/11/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +23.31% since 07/02/24 | -15.65% since 07/02/24 | +34.74% since 07/02/24 | +40.82% since 07/02/24 | -13.87% since 07/02/24 |
| Low | 67.68 on 07/03/24 | 253.30 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 |
| High | 93.45 on 11/11/24 | 346.85 on 07/25/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,854,539 | 140,102,608 | 115,117,592 | 114,713,688 | 103,706,928 |
| Shares Outstanding, K | 106,017 | 537,533 | 1,246,266 | 2,028,177 | 257,529 |
| Annual Sales | 464,370,000 | 28,190,000,000 | 27,116,000,000 | 45,006,000,000 | 9,869,200,000 |
| Annual Net Income | -139,670,000 | 6,717,000,000 | 5,665,000,000 | 8,025,000,000 | 3,619,600,000 |
| Last Quarter Sales | 175,380,000 | 8,503,000,000 | 7,545,000,000 | 11,892,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -26,320,000 | 2,830,000,000 | 1,253,000,000 | 1,211,000,000 | 1,045,400,000 |
| 60-Month Beta | 0.95 | 0.55 | 0.18 | 0.45 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 10/30/24 | 5.58 on 10/30/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 10/30/24 | 02/04/25 | 02/11/25 | 02/06/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.770 on 12/13/24 | 0.620 on 01/03/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 12/13/24 | 01/03/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.49 | 20.77 | 47.91 | 0.00 |